EKAPARTNERS advised SUBSTIPHARM on its syndicated loan to pursue a proactive external growth.

We acted as financial advisors to Substipharm on its first structured financing supported by LCL, Banque Palatine, Societe Generale Corporate & Investment Banking, Banque Populaire Rives de Paris and Neuflize OBC.

Substipharm is a fast growing leader in the development of generic or niche pharmaceutical products.